Therefore, we carried out a meta-analysis on all eligible case-control studies to estimate the overall gastric cancer risk of MDM2 SNP309 polymorphism as well as to quantify the between-study heterogeneity and potential bias. Here, MDM2 is linked to gastric cancer.